牛牛AI助理已提取核心訊息
Michael Terrence Gibbs, General Counsel of T2 Biosystems, Inc. (TTOO), executed a transaction on February 20, 2024, involving the acquisition of 40 shares of common stock. The transaction, classified under the code 'M', indicates an exercise or conversion of derivative security. Following this transaction, Gibbs directly holds a total of 106 shares in the company. The action reflects a continued investment by a key insider in the firm's equity.
Michael Terrence Gibbs, General Counsel of T2 Biosystems, Inc. (TTOO), executed a transaction on February 20, 2024, involving the acquisition of 40 shares of common stock. The transaction, classified under the code 'M', indicates an exercise or conversion of derivative security. Following this transaction, Gibbs directly holds a total of 106 shares in the company. The action reflects a continued investment by a key insider in the firm's equity.
T2 Biosystems, Inc.（TTOO）總法律顧問邁克爾·特倫斯·吉布斯於2024年2月20日執行了一項交易，涉及收購40股普通股。該交易被歸類爲 “M”，表示行使或轉換衍生證券。在這筆交易之後，吉布斯直接持有該公司的總共106股股份。該行動反映了一位主要內部人士對公司股票的持續投資。
T2 Biosystems, Inc.（TTOO）總法律顧問邁克爾·特倫斯·吉布斯於2024年2月20日執行了一項交易，涉及收購40股普通股。該交易被歸類爲 “M”，表示行使或轉換衍生證券。在這筆交易之後，吉布斯直接持有該公司的總共106股股份。該行動反映了一位主要內部人士對公司股票的持續投資。
有用
沒用